Biblio Discovery — Demo Discovery Service

1.916 hasil

Menampilkan 1–20 · 0,46 detik · RSS

Jurnal

Saudi Pharmaceutical Journal

Scopus

ISSN 1319-0164 · Springer · 1.916 artikel di indeks

  1. Artikel Jurnal

    Essence of toxicology research to Saudi Arabia Vision 2030 and beyond: Current state and future perspectives

    Nasser B. Alsaleh

    Saudi Pharmaceutical Journal, Vol. 34 No. 1 · 2026 · Inggris · DOAJ Scopus

    Abstract The Kingdom of Saudi Arabia has been making significant progress as part of its Vision 2030 to diversify its economy and reduce dependence on fossil fuels. Key components of this transformation include the development of a robust research and development (R&D) ecosystem and…

  2. Artikel Jurnal

    Discovery of a novel VEGFR2 inhibitor using integrated structure-based docking study and functional validation: potential applications in targeted cancer therapy

    Hussam Albassam; Saad Alobid; Faris Almutairi dkk.

    Saudi Pharmaceutical Journal, Vol. 34 No. 1 · 2026 · Inggris · DOAJ Scopus

    Abstract Cancer remains a predominant cause of mortality worldwide, with conventional therapies often limited by adverse side effects and the development of drug resistance. Targeting receptor tyrosine kinases (RTKs), especially vascular endothelial growth factor receptor 2 (VEGFR2), presents a…

  3. Artikel Jurnal

    Targeting the PI3K/AKT/mTOR signaling pathway in prostate cancer: Molecular dysregulation, therapeutic advances, and future directions

    Saad Alobid

    Saudi Pharmaceutical Journal, Vol. 34 No. 1 · 2026 · Inggris · DOAJ Scopus

    Abstract Prostate cancer (PCa) is among the most common malignancies and remains a leading cause of cancer-related mortality in men worldwide. One of the main drivers is the dysregulation of the downstream signalling machinery. The PI3K, AKT, and mTOR signalling pathways play a pivotal role in…

  4. Artikel Jurnal

    Empagliflozin improves renal injury of diabetic nephropathy complicated with hyperuricemia through AMPK by promoting autophagy and inhibiting apoptosis

    Zhiqin Zhang; Yanmei Xu; Chuanwen Xu dkk.

    Saudi Pharmaceutical Journal, Vol. 34 No. 1 · 2026 · Inggris · DOAJ Scopus

    Abstract Objective This study aimed to investigate how empagliflozin alleviates renal injury in diabetic nephropathy with hyperuricemia by activating AMPK and regulating autophagy and apoptosis. Methods This study incorporated clinical renal tissue samples, diabetic-hyperuricemic mouse models, and…

  5. Artikel Jurnal

    Comorbidities and mortality in colistin-resistant gram-negative infections among hospitalized patients in Qassim, Saudi Arabia

    Masaad Saeed Almutairi; Mohammed Albulaihed; Faisal Almutairi dkk.

    Saudi Pharmaceutical Journal, Vol. 34 No. 1 · 2026 · Inggris · DOAJ Scopus

    Abstract Colistin has served as a last-resort agent against multidrug-resistant Gram-negative bacilli (MDR-GNB). However, the emergence of resistance has substantially eroded its therapeutic value, particularly among hospitalized patients. Evidence regarding the clinical outcomes of…

  6. Artikel Jurnal

    Risk of drug eruption associated with the use of tetracyclines, macrolides, and fluoroquinolones: real-world evidence from a pharmacovigilance study utilizing the FDA adverse event reporting system

    Thamir M. Alshammari

    Saudi Pharmaceutical Journal, Vol. 34 No. 1 · 2026 · Inggris · DOAJ Scopus

    Abstract Recently, concerns regarding the risk of drug eruption associated with the use of tetracyclines were raised by the United States Food and Drug Administration (U.S. FDA). Therefore, it is necessary to reevaluate this risk. This study aimed to quantify the signal of drug eruption associated…

  7. Artikel Jurnal

    Pharmacogenomics knowledge, attitudes, and perceptions among pharmacists in the Asir Region, Saudi Arabia: a cross-sectional analysis

    Saud Alqahtani; Taha Alqahtani; Krishnaraju Venkatesan dkk.

    Saudi Pharmaceutical Journal, Vol. 34 No. 1 · 2026 · Inggris · DOAJ Scopus

    Abstract As personalized medicine progresses in Saudi Arabia, pharmacists endure a central role in pharmacogenomics (PGx) implementation. This cross-sectional study weighed the knowledge, attitudes, and perceptions (KAP) of pharmacists in the Asir region regarding PGx, a region with limited…

  8. Artikel Jurnal

    Nanocarrier-mediated CRISPR-Cas delivery: a novel approach against antibiotic-resistant superbugs

    Fawaz M. Almufarriji

    Saudi Pharmaceutical Journal, Vol. 34 No. 1 · 2026 · Inggris · DOAJ Scopus

    Abstract Antibiotic resistance (ABR) is a leading cause of death and a major public health threat globally. Without appropriate interventions, annual ABR-associated deaths have been projected to reach 10 million by 2050 worldwide. Hence, it is critical to develop novel therapeutic interventions…

  9. Artikel Jurnal

    Virtual bioequivalence-guided PBBM prediction for ibuprofen/diphenhydramine citrate tablets: impact of dissolution variability and clinical standard development

    Zilong Wang; Zhihai Cao; Chun Guo dkk.

    Saudi Pharmaceutical Journal, Vol. 34 No. 5 · 2026 · Inggris · DOAJ Scopus

    Abstract This study aimed to integrate in vitro dissolution testing, in vivo pharmacokinetic (PK) studies, and computational simulation to develop a physiologically based biopharmaceutics model (PBBM) for fixed-dose combination ibuprofen/diphenhydramine citrate tablets, thereby evaluating…

  10. Artikel Jurnal

    Regional research priorities for medication safety and pharmacovigilance in gulf cooperation council countries: a modified Delphi consensus study

    Ghadah A. Assiri; Wael Y. Khawagi; Huda Alewairdhi dkk.

    Saudi Pharmaceutical Journal, Vol. 34 No. 4 · 2026 · Inggris · DOAJ Scopus

    Abstract Adverse drug reactions (ADRs) and medication errors remain major global threats to patient safety. Although Gulf Cooperation Council (GCC) countries have advanced medication safety and pharmacovigilance programs, research priorities remain fragmented and lack expert consensus. To establish…

  11. Artikel Jurnal

    Bridging the clinical trial gap in Saudi Arabia: a multi-stakeholder conference-based consensus on strategic initiatives for global competitiveness and patient inclusion

    Majed Al Jeraisy; Eva Turgonyi; Vladimir Misik dkk.

    Saudi Pharmaceutical Journal, Vol. 34 No. 4 · 2026 · Inggris · DOAJ Scopus

    Abstract Background The clinical trial ecosystem of Saudi Arabia has advanced significantly, with innovative industry-sponsored clinical trials (iCTs) growing by 27% from 2018 to 2023, reaching 51.4% in the first half of 2025. However, the Kingdom remains underrepresented in global research. This…

  12. Artikel Jurnal

    Gut microbiota modulation of systemic immunity and cancer immunotherapy: mechanisms, evidence, and therapeutic implications

    Bader S. Alotaibi

    Saudi Pharmaceutical Journal, Vol. 34 No. 4 · 2026 · Inggris · DOAJ Scopus

    Abstract The gut microbiota plays a critical role in regulating systemic immune responses and has emerged as a key determinant of therapeutic efficacy and toxicity in cancer immunotherapy. Accumulating evidence indicates that specific microbial taxa and microbiota-derived metabolites modulate…

  13. Artikel Jurnal

    Adherence to evidence-based guidelines for the management of candiduria in a tertiary care center in Riyadh: A retrospective cross-sectional study

    Mohammed Alessa; Sulaiman Alzunaydi; Hattan Y. Alfaqeeh dkk.

    Saudi Pharmaceutical Journal, Vol. 34 No. 4 · 2026 · Inggris · DOAJ Scopus

    Abstract According to the Infectious Disease Society of America (IDSA) 2016 guidelines for the management of candidiasis, the presence of Candida in the urine in asymptomatic patients is usually a colonization rather than an infection, which does not require antifungals treatment. This study aims…

  14. Artikel Jurnal

    Developing a medical-device formulary for council of health insurance beneficiaries in Saudi Arabia: stakeholder challenges and policy recommendations

    Shabab Alghamdi; Ibrahim Aljuffali; Nada Alagil dkk.

    Saudi Pharmaceutical Journal, Vol. 34 No. 4 · 2026 · Inggris · DOAJ Scopus

    Abstract Ensuring equitable access to dispensed-to-patient (DTP) medical devices is an important policy priority for health insurance systems. This mixed-method study examined stakeholder perspectives on barriers and policy priorities for developing a DTP medical-device formulary for health…

  15. Artikel Jurnal

    LC-ESI-TOF–MS profiling and protective effects of Psidium cattleianum extract against gentamicin-induced nephrotoxicity in rats via Nrf2/HO-1 and caspase-dependent pathway

    Hoda M. Hassan; Heba T. Khazaal; Fatma A. Moharram dkk.

    Saudi Pharmaceutical Journal, Vol. 34 No. 4 · 2026 · Inggris · DOAJ Scopus

    Abstract Drug-induced nephrotoxicity is an alarming trigger for kidney injury. It is linked to a high rate of illness and fatality, with limited treatment options. Herein, we aimed to unravel the phytochemical profile and understand the protective activity of the aqueous methanolic extract (AME) of…

  16. Artikel Jurnal

    Biogenic chitosan-encapsulated Cu/ZnO nanocomposite surface coating inhibits MDR Pseudomonas aeruginosa biofilm establishment on orthopedic implants

    Bushra Uzair; Zukhra Abbasi; Fehmida Fasim dkk.

    Saudi Pharmaceutical Journal, Vol. 34 No. 4 · 2026 · Inggris · DOAJ Scopus

    Abstract Orthopedic implant-associated infections (IAIs), predominantly caused by Pseudomonas aeruginosa, represent a major clinical challenge due to antibiotic resistance and biofilm formation, which together contribute to their chronic nature. This research presents a biogenic biofilm-resistant…

  17. Artikel Jurnal

    Rhein and its derivatives: potential anti-tumor drugs and corresponding targeted mechanism

    Xiaoli Li; Taotao Li; Yuan Ma dkk.

    Saudi Pharmaceutical Journal, Vol. 34 No. 4 · 2026 · Inggris · DOAJ Scopus

    Abstract Cancer remains a major global health threat with high morbidity and mortality, and clinical treatment is plagued by drug resistance, poor efficacy and severe side effects, driving the search for novel anti-tumor agents from natural products. Rhein, a natural anthraquinone abundant in Rheum…

  18. Artikel Jurnal

    A real-world, bottom-up cost of illness analysis of type 2 diabetes mellitus from a tertiary hospital in Saudi Arabia

    Saleh Alyahya; Saif Alhawwashi; Saad Saeed Alqhatani dkk.

    Saudi Pharmaceutical Journal, Vol. 34 No. 4 · 2026 · Inggris · DOAJ Scopus

    Abstract Type 2 diabetes mellitus (T2DM) is a major contributor to global morbidity, mortality, and healthcare expenditure. In the context of Saudi Arabia, it is concerningly notable that the prevalence of T2DM is particularly high and rising. Existing cost estimates have previously relied rely on…

  19. Artikel Jurnal

    Formononetin attenuates glucocorticoid-induced osteoporosis via multiple osteoimmunological pathways: evidence from zebrafish and network pharmacology

    Xuting Song; Min He; Jingran Cui dkk.

    Saudi Pharmaceutical Journal, Vol. 34 No. 4 · 2026 · Inggris · DOAJ Scopus

    Abstract Osteoporosis is a prevalent metabolic bone disease that requires multi-target therapeutic strategies. Formononetin (FMN), a bioactive isoflavone derived from Astragalus species, has shown potential in promoting bone health; however, its systemic mechanisms remain poorly understood. In this…

  20. Artikel Jurnal

    Phytochemicals with potential NMDAR-inhibitory activities: a review of neuroprotective mechanisms against excitotoxicity

    Abdulmohsin J. Alamoudi

    Saudi Pharmaceutical Journal, Vol. 34 No. 4 · 2026 · Inggris · DOAJ Scopus

    Abstract The N-methyl-D-aspartate receptors (NMDARs) are ionotropic glutamate receptors in the central nervous system (CNS) that play a crucial role in synaptic plasticity, learning, and memory. However, NMDAR overstimulation is a critical pathological feature in neurodegenerative diseases, stroke…

Menampilkan maksimal 50 halaman. Persempit pencarian dengan filter untuk hasil yang lebih spesifik.